Horizons in Hemophilia, October 2014
Trish Dominic to Retire in June 2015
Trish Dominic, CEO of Hemophilia of Georgia, has announced her plans to retire. During her tenure, Hemophilia of Georgia has grown to become one of the leading hemophilia organizations in the world.
NHF Lifetime Achievement Award to Trish Dominic
On September 20, 2014, Trish Dominic, Hemophilia of Georgia’s CEO, received the Lifetime Achievement Award from the National Hemophilia Foundation (NHF) at its Annual Meeting in Washington, D.C.
Atlanta Braves and HoG Hall of Fame Celebration
Three Atlanta Braves legends were inducted into the Hall of Fame in Cooperstown this past July and in honor of the long standing partnership with the team, Hemophilia of Georgia is celebrating this defining moment in Braves history throughout the month of October.
Are you Ready to Vote this November?
My father and I have never agreed on political candidates. We’ve ruined many a Thanksgiving dinner in misguided attempts at convincing one another to swing towards the opposite end of the political spectrum.
Researchers Report Advances in Plant-Based Hemophilia A Therapy
A team of researchers from the University of Florida, Gainesville (UF-G) and University of Pennsylvania (U-Penn) are developing a novel approach to tackling inhibitors in hemophilia A that uses genetically engineered plant cells.
Fall Family Camp
September 5-7 was a perfect weekend to enjoy time as a family at Camp Twin Lakes. Families participated in an educational session that taught fun ways to increase physical activity as a family.
In the News: RIXUBIS is now approved for both adults and children
Baxter announces the pediatric indication for Rixubis by the FDA. The approved indication is for both routine prophylaxis and control of bleeding episodes for children with hemophilia B.
View the clinic schedules for the Georgia Hemophilia Treatment Centers.
Have you read HoG's Blog?
